Search results
Experimental NIH Antibody Protects Children From Malaria in Clinical Trial
SciTechDaily· 3 hours agoA new study reports a single dose of a malaria antibody was 77% effective in protecting children in...
Radiance Biopharma to Present at LSX World Congress 2024
Digital Journal· 2 hours ago...London Time) BOSTON MA / ACCESSWIRE / April 26, 2024 / Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that Robert Brooks,...
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 1 day agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
Man receives world’s first melanoma vaccine — trial underway
New York Post· 36 minutes agoA trial for the world’s first-ever mRNA cancer vaccine for melanoma is underway in the UK. Melanoma...
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 4 hours agoA $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab Thursday ...
Study finds RSV treatment Beyfortus prevents 5,800 hospitalisations in France
Euronews via Yahoo News· 7 hours agoRoughly 5,800 hospitalisations from bronchiolitis were avoided in France thanks to the new...
Dengue Fever
Health via Yahoo News· 2 hours agoBlood tests can be ordered to rule out other possible illnesses. There are two main types of blood tests used to diagnose dengue: antibody and molecular...
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
WRBL Columbus· 2 days agoFirst-in-class PD-1/IL-2 bispecific antibody fusion protein IBI363 in patients with advanced colorectal cancer: Safety and efficacy results from a phase I study. First-in-class ...
Study confirms effectiveness of bivalent COVID-19 vaccine
Medical Xpress· 22 hours agoThe scientists investigated the antibody neutralization response against different variants of...
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug...
Morningstar· 3 days agoBRIDGEWATER, NJ / ACCESSWIRE / April 23, 2024 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates ...
